Multiple ways of silencing E-cadherin gene expression in lobular carcinoma of the breast

International Journal of Cancer

Volumn 92, Issue 3, 2001, Pages 404-408

  Droufakou, Stavroula ^a   Deshmane, Vinay ^a   Roylance, Rebecca ^b   Hanby, Andrew ^b   Tomlinson, Ian ^a,c   Hart, Ian R ^a,b  

^a ST THOMAS HOSPITAL   (United Kingdom)

^b IMPERIAL CANCER RESEARCH FUND   (United Kingdom)

^c GUY S HOSPITAL   (United Kingdom)

Author keywords

Breast lobular carcinoma; E cadherin; LOH; Promoter methylation

Indexed keywords

UVOMORULIN;

ALLELE; ARTICLE; BREAST CARCINOMA; CELL ADHESION; CLINICAL ARTICLE; CLONING; EPITHELIUM CELL; EXON; FEMALE; FRAMESHIFT MUTATION; GEL ELECTROPHORESIS; GENE; GENE EXPRESSION; GENE MUTATION; HETERODUPLEX ANALYSIS; HETEROZYGOSITY LOSS; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INTRON; METHYLATION; MORPHOGENESIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; SCREENING TEST; STOP CODON;

BREAST NEOPLASMS; CADHERINS; CARCINOMA, LOBULAR; DNA METHYLATION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE SILENCING; HUMANS; IMMUNOHISTOCHEMISTRY; LOSS OF HETEROZYGOSITY; MUTATION; PROMOTER REGIONS (GENETICS);

EID: 0035342577     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/ijc.1208     Document Type: Article

References (43)

1. Cadherin cell adhesion receptors as a morphogenetic regulator
2. Cadherin-catenin complex: Protein interactions and their implications for cadherin function
3. The E-cadherin promoter-functional analysis of a G-C rich region and an epithelial cell-specific palindromic regulatory element
4. E-cadherin relates to EGFR expression and lymph node metastasis in primary breast carcinoma
5. Expression of E-cadherin cell adhesion molecules in human breast cancer tissues and its relationship to metastasis
6. Reduced E-cadherin expression is associated with invasiveness and unfavorable prognosis in breast cancer
7. Expression of E-cadherin (E-CD) as related to other prognostic factors and survival in breast-cancer
8. Differential loss of E-cadherin expression in infiltrating ductal and lobular breast carcinomas
9. Epithelial (E) and placental (P-)cadherin cell adhesion molecule expression in breast carcinoma
10. Simultaneous loss of E-cadherin and catenins in invasive lobular breast cancer and lobular carcinoma in situ
11. E cadherin and alpha, beta and gamma catenin expression in relation to metastasis in human breast carcinoma
12. E-cadherin is inactivated in a majority of invasive human lobular breast cancers by truncation mutations throughout its extracellular domain
13. Chromosome alterations and E-cadherin gene mutations in human lobular breast cancer
14. E-cadherin gene mutations provide clues to diffuse type gastric carcinomas
15. Mutations of the E-cadherin gene in human gynecologic cancers
16. E cadherin gene alterations are rare events in thyroid tumours
17. Identification of germ-line E-cadherin mutations in gastric cancer families of European origin
18. E-cadherin germline mutations in familial gastric cancer
19. Diffuse type gastric and lobular breast carcinoma in a familial gastric cancer patient with an E-cadherin germline mutation
20. Lobular carcinoma in situ of the breast is not caused by constitutional mutations in the E-cadherin gene
21. Level of expression of E-cadherin mRNA in colorectal cancer correlates with clinical outcome
22. E-cadherin expression is silenced by DNA hypermethylation in human breast and prostate carcinomas
23. The interactions of APC, E-cadherin and b-catenin in tumour development and progression
24. The biological and prognostic significance of cell polarity and E-cadherin in grade I infiltrating ductal carcinoma of the breast
25. Conformation-sensitive gel electroforesis for rapid detection of single-base differences in double-stranded PCR products and DNA fragments: Evidence for solvent-induced bends in DNA heteroduplexes
26. Methylation-specific PCR: A novel PCR assay for methylation status of CpG islands
27. PCR bias toward the wild type k-fas and p53 sequences: Implications for PCR detection of mutations and cancer diagnosis
28. Inhibition of a PCR amplification by a point mutation downstream of a primer
29. Comparative genomic hybridization of breast tumors stratified by histological grade reveals new insights into the biological progression of breast cancer
30. A single nucleotide polymorphism in the E-cadherin gene promoter alters transcriptional activities
31. Mechanisms of inactivation of E-cadherin in breast cancer cell lines
32. Re-expression of E-cadherin, a-catenin and b-catenin, but not of beta-catenin, in metastatic tissue from breast cancer patients
33. Adhesion molecule expression in breast cancer: The phoenix in tumour metastasis
34. Methylation patterns of the E-cadherin 5′ CpG island are unstable and reflect the dynamic, heterogeneous loss of E-cadherin expression during metastatic progression
35. E-cadherin is a tumour/invasion suppressor gene mutated in human lobular breast cancers
36. Mutations of the human E-cadherin (CDH1) gene
37. Tumour-associated E-cadherin mutations alter cellular morphology, decrease cellular adhesion and increase cellular motility
38. Point mutation of the E-cadherin gene in invasive lobular carcinoma of the breast
39. Reproducibility of a diagnosis of invasive lobular carcinoma
40. Higher sensitivity of denaturing gradient gel electrophoresis than sequencing in the detection of mutations in DNA from tumor samples
41. Tamoxifen restores the E cadherin function in human breast cancer MCF-7/6 cells and suppresses their invasive phenotype
42. Activation of the E-cadherin/catenin complex in human MCF-7 breast cancer cells by all-trans-retinoid acid
43. Recommendations for a nomenclature system for human gene mutations